ZyVersa Therapeutics, Inc.
ZVSA
$0.7899
-$0.0111-1.39%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 122.90K | 119.50K | 2.03M | 3.14M | 1.58M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 267.50K | 521.90K | 866.50K | 215.50K | 426.50K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 390.40K | 641.40K | 2.90M | 3.35M | 2.01M |
|
|
|||||
| Total Current Assets | 390.40K | 641.40K | 2.90M | 3.35M | 2.01M |
| Net Property, Plant & Equipment | -- | 1.70K | 4.30K | 14.80K | 40.60K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 18.65M | 18.65M | 18.65M | 18.65M | 30.81M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 385.60K | 178.50K | 98.50K | 98.50K | -- |
| Total Assets | 19.42M | 19.47M | 21.65M | 22.11M | 32.85M |
|
|
|||||
| Total Accounts Payable | 9.28M | 8.32M | 8.13M | 8.43M | 8.90M |
| Total Accrued Expenses | 2.25M | 1.67M | 1.45M | 1.25M | 2.14M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | 8.70K | 34.30K |
| Total Finance Division Other Current Liabilities | 7.30K | 7.30K | 7.30K | 507.30K | 636.70K |
| Total Other Current Liabilities | 7.30K | 7.30K | 7.30K | 507.30K | 636.70K |
| Total Current Liabilities | 11.54M | 9.99M | 9.58M | 10.19M | 11.71M |
|
|
|||||
| Total Current Liabilities | 11.54M | 9.99M | 9.58M | 10.19M | 11.71M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 854.60K | 854.60K | 844.90K | 844.90K | 1.44M |
| Total Liabilities | 12.40M | 10.85M | 10.43M | 11.04M | 13.15M |
|
|
|||||
| Common Stock & APIC | 118.25M | 117.44M | 117.28M | 114.30M | 109.59M |
| Retained Earnings | -111.21M | -108.81M | -106.05M | -103.22M | -89.88M |
| Treasury Stock & Other | -7.20K | -7.20K | -7.20K | -7.20K | -7.20K |
| Total Common Equity | 7.03M | 8.62M | 11.22M | 11.07M | 19.70M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
|
|||||
| Total Common Equity | 7.03M | 8.62M | 11.22M | 11.07M | 19.70M |
| Total Preferred Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 7.03M | 8.62M | 11.22M | 11.07M | 19.70M |
|
|
|||||
